Financial reports
10-Q
2013 Q3
Quarterly report
7 Nov 13
ARS
2012 FY
Annual report to shareholders
3 Oct 13
10-Q
2013 Q2
Quarterly report
6 Aug 13
10-Q
2013 Q1
Quarterly report
9 May 13
10-K/A
2012 FY
Annual report (amended)
11 Apr 13
10-K
2012 FY
Annual report
14 Mar 13
10-Q
2012 Q3
Quarterly report
8 Nov 12
10-Q
2012 Q2
Quarterly report
9 Aug 12
10-Q
2012 Q1
Quarterly report
15 May 12
ARS
2011 FY
Annual report to shareholders
24 Apr 12
Current reports
8-K
Cornerstone Therapeutics Inc. Stockholders Approve Merger
4 Feb 14
8-K
Cornerstone Therapeutics Adjourns Special Meeting of Stockholders
3 Feb 14
8-K
Cornerstone Therapeutics Reports Third Quarter 2013 Financial Results
7 Nov 13
8-K
Submission of Matters to a Vote of Security Holders
31 Oct 13
8-K
Departure of Directors or Certain Officers
19 Sep 13
8-K
Entry into a Material Definitive Agreement
16 Sep 13
8-K
Amendments to Articles of Incorporation or Bylaws
16 Sep 13
8-K
Other Events
20 Aug 13
8-K
Departure of Directors or Certain Officers
8 Aug 13
8-K
Cornerstone Therapeutics Reports Second Quarter 2013
6 Aug 13
Registration and prospectus
15-12G
Securities registration termination
14 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
RW
Registration withdrawal request
5 Feb 14
25-NSE
Exchange delisting
4 Feb 14
Proxies
DEFA14A
Additional proxy soliciting materials
3 Feb 14
DEFM14A
Proxy related to merger
26 Dec 13
PRER14A
Preliminary revised proxy
13 Dec 13
PRER14A
Preliminary revised proxy
27 Nov 13
PREM14A
Preliminary proxy related to merger
17 Oct 13
DEF 14A
Definitive proxy
3 Oct 13
DFAN14A
Additional proxy materials by non-management
19 Sep 13
DEFA14A
Additional proxy soliciting materials
16 Sep 13
DEFA14A
Additional proxy soliciting materials
16 Sep 13
DEF 14A
Definitive proxy
23 Apr 12
Other
CORRESP
Correspondence with SEC
13 Dec 13
UPLOAD
Letter from SEC
9 Dec 13
CORRESP
Correspondence with SEC
27 Nov 13
UPLOAD
Letter from SEC
12 Nov 13
UPLOAD
Letter from SEC
12 Nov 13
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
7 Nov 13
CT ORDER
Confidential treatment order
27 Aug 13
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
6 Aug 13
CT ORDER
Confidential treatment order
17 May 13
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
9 May 13
Ownership
SC 13D/A
Cornerstone Therapeutics Inc
7 Feb 14
SC 13D/A
Cornerstone Therapeutics Inc
4 Feb 14
SC 13D/A
Cornerstone Therapeutics Inc
20 Sep 13
SC 13D/A
Cornerstone Therapeutics Inc
16 Sep 13
SC 13D/A
Chiesi Farmaceutici SpA
19 Feb 13
SC 13D/A
Chiesi Farmaceutici SpA
9 Jul 12
SC 13D/A
Chiesi Farmaceutici SpA
17 Apr 12
SC 13D/A
Cornerstone BioPharma Holdings, Ltd.
5 Apr 12
SC 13D/A
Cornerstone BioPharma Holdings, Ltd.
21 Dec 10
SC 13D/A
Chiesi Farmaceutici SpA
20 Dec 10